The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA profiling of patients with metastatic luminal HER2-low and HER2-0 breast cancer via next-generation sequencing.
 
Nina Dobric
No Relationships to Disclose
 
Nadia Dandachi
No Relationships to Disclose
 
Eva Valentina Klocker
Honoraria - AstraZeneca; Lilly; Novartis; Roche; Stemline Therapeutics
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Pierre Fabre; Roche
 
Christoph Suppan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre
 
Ricarda Graf
No Relationships to Disclose
 
Isaac Lazzeri
Patents, Royalties, Other Intellectual Property - Medical University of Graz
 
Carmen Albertini
No Relationships to Disclose
 
Gabriel Rinnerthaler
Honoraria - Amgen; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Stemline Therapeutics
Research Funding - Daiichi Sankyo (Inst); Lilly (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Gilead Sciences; Lilly
 
Angelika Starzer
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD; Stemline Therapeutics
 
Rupert Bartsch
Honoraria - AstraZeneca; Daiicho; Lilly; Novartis; Pfizer; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi; Eisai; Lilly; MSD Oncology; MSD Oncology; Novartis; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Puma Biotechnology; Roche; Seagen
Research Funding - Daiichi (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Pfizer; Pfizer; Roche; Roche
 
Samantha Hasenleithner
Patents, Royalties, Other Intellectual Property - Medical University of Graz
Travel, Accommodations, Expenses - AstraZeneca
 
Philipp Jost
Employment - Leucotox GmbH
Stock and Other Ownership Interests - Leucotox GmbH, Austria; Vessel FlexCo
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim Austria; Bristol-Myers Squibb; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Janssen
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - MLKL 1/04/2014 Author - Other Eligible Papers cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner; Title of Invention: LYMPHOTOXIN ALPHA FOR USE IN THERAPY OF MYELOID LEUKEMIA European Patent Application Number: 20727596.7 International Application Number: PCT/EP2020/063609; Venetoclax 1/01/2009 Author - Other Eligible Papers Fatal Hepatitis Mediated by Tumor Necrosis Factor TNF alpha Requires Caspase-8 and Involves the BH3-Only Proteins Bid and Bim 1; Venetoclax 1/01/2009 Author - Other Eligible Papers XIAP discriminates between type I and type II FAS-induced apoptosis 1; Venetoclax 1/01/2010 Author - Other Eligible Papers Mcl-1 Is essential for germinal center formation and B cell memory 1
Travel, Accommodations, Expenses - See section on Honoraria
 
Ellen Heitzer
Honoraria - AstraZeneca; Incyte; Roche
Consulting or Advisory Role - Roche
Research Funding - Illumina (Inst); Roche (Inst)
Travel, Accommodations, Expenses - PreAnalyitiX
 
Marija Balic
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pfizer; Pierre Fabre; Roche; Samsung; Seagen
Speakers' Bureau - Amgen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca (Inst); Daichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - MSD